Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs
Top Cited Papers
Open Access
- 30 April 2025
- journal article
- review article
- Published by Springer Nature in Bone Research
- Vol. 13 (1) , 1-28
Abstract
Bone has long been acknowledged as a fundamental structural entity that provides support and protection to the body’s organs. However, emerging research indicates that bone plays a crucial role in the regulation of systemic metabolism. This is achieved through the secretion of a variety of hormones, cytokines, metal ions, extracellular vesicles, and other proteins/peptides, collectively referred to as bone-derived factors (BDFs). BDFs act as a medium through which bones can exert targeted regulatory functions upon various organs, thereby underscoring the profound and concrete implications of bone in human physiology. Nevertheless, there remains a pressing need for further investigations to elucidate the underlying mechanisms that inform the effects of bone on other body systems. This review aims to summarize the current findings related to the roles of these significant modulators across different organs and metabolic contexts by regulating critical genes and signaling pathways in vivo. It also addresses their involvement in the pathogenesis of various diseases affecting the musculoskeletal system, circulatory system, glucose and lipid metabolism, central nervous system, urinary system, and reproductive system. The insights gained from this review may contribute to the development of innovative therapeutic strategies through a focused approach to bone secretomes. Continued research into BDFs is expected to enhance our understanding of bone as a multifunctional organ with diverse regulatory roles in human health.Keywords
This publication has 283 references indexed in Scilit:
- Natural Plant Tissue with Bioinspired Nano Amyloid and Hydroxyapatite as Green Scaffolds for Bone RegenerationAdvanced Healthcare Materials, 2022
- Myeloid‐derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiationGlia, 2020
- Osteopontin Takes Center Stage in Chronic Liver DiseaseHepatology, 2020
- Regulation of fibroblast growth factor 23 ( FGF 23) in health and diseaseFEBS Letters, 2019
- A Complex Role for Lipocalin 2 in Bone Metabolism: Global Ablation in Mice Induces Osteopenia Caused by an Altered Energy MetabolismJournal of Bone and Mineral Research, 2018
- Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat DepotsJournal of Bone and Mineral Research, 2016
- Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic HypophosphatemiaJournal of Bone and Mineral Research, 2016
- FGF23 regulates renal sodium handling and blood pressureEMBO Molecular Medicine, 2014
- Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophyJournal of Bone and Mineral Research, 2012
- Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones.The EMBO Journal, 1986